FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!!

Similar documents
Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

FFR Incorporating & Expanding it s use in Clinical Practice

Fractional Flow Reserve (FFR) --Practical Set Up Pressure Measurement --

FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls

Fractional Flow Reserve: Review of the latest data

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

FFR in Multivessel Disease

Coronary stenting: the appropriate use of FFR

Benefit of Performing PCI Based on FFR

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

Dave Kettles, St Dominics Hospital East London.

CLINICAL CONSEQUENCES OF THE

Fractional Flow Reserve and instantaneous wave -free Ratio. Λάμπρος Κ. Μόσιαλος Επεμβατικός Καρδιολόγος ΓΝ Παπαγεωργίου

FFR: Tips and Tricks. A/Prof (Adj) Yeo Khung Keong, MBBS, FAMS, FACC, FSCAI National Heart Centre Singapore

Debate Should we use FFR? I will say NO.

Pressure Wire Study. Fractional Flow Reserve (FFR) Nishat Jahagirdar Principal Clinical Cardiac Physiologist Kings College Hospital

Fractional Flow Reserve. A physiological approach to guide complex interventions

Cost-Effectiveness of Fractional Flow Reserve

FFR in diffuse disease and serial stenoses

Technical Aspects and Clinical Indications of FFR

FFR in Left Main Disease

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

Do stents deserve the bad press? Mark A. Tulli MD, FACC

Coronary Physiology and FFR. David H. Sibley MD FACC, FSCAI, FACP

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Diffuse Disease and Serial Stenoses

Fractional Flow Reserve (FFR) estimation GRAIDIS CHRISTOS. EUROMEDICA-KYΑNOUS STAVROS Interventional Cardiologist, FSCAI

Fractional Flow Reserve and the 1 Year Results of the FAME Study

Management of stable CAD FFR guided therapy: the new gold standard

Fractional Flow Reserve and the Results of the FAME Study

New Insight about FFR and IVUS MLA

Diffuse Disease and Serial Stenoses. Bernard De Bruyne Cardiovascular Center Aalst Belgium

Instantaneous Wave-Free Ratio

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Coronary artery disease (CAD): Fractional Flow Reserve (FFR) for Pilots Risk Assessment. B. Haaff, R. Quast

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Prognostic Value of Gated Myocardial Perfusion SPECT

La FFR quoi d autre: En pratique? Pierre Deharo, CHU TIMONE, Marseille

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

Focus on Acute Coronary Syndromes

PressureWire Aeris with Agile Tip Technology. Wireless FFR Functionality and Handles like a Workhorse PCI Guidewire 1

FFR and intravascular imaging, which of which?

Diagnostic Challenges

FFR= Qs/Qn. Ohm s law R= P/Q Q=P/R

Case Review: Borderline LM with IVUS and FFR. Ravi Ramana, DO Heart Care Centers of Illinois SCAI Annual Conference 2010

Aun-Yeong Chong MD, MRCP(UK), MBBS University of Ottawa Heart Institute

FFR vs icecg in Coronary Bifurcations FIESTA ClinicalTrials.gov Identifier: NCT

Fractional Flow Reserve (FFR)

Coronary interventions

The Future of Coronary Physiology

Control of Myocardial Blood Flow

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

ABSOLUTE BLOOD FLOW MEASUREMENTS: PRINCIPLES

Between Coronary Angiography and Fractional Flow Reserve

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

CT or PET/CT for coronary artery disease

FFR? FFR-CT? Ischaemia testing?

Case report. Resistance in the cath lab : the utility of hyperemic stenosis resistance in the functional assessment of coronary artery disease

Physiology (FFR & IFR) is Essential in Daily Pratice. Martine Gilard Brest University - France

FFR in unstable angina and after MI F

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

What do the guidelines say?

Integrated Use of IVUS and FFR for LM Stenting

Anatomy is Destiny, But Physiology is Here Today

Post PCI functional testing and imaging: case based lessons from FFR React

Left Main Intervention: Where are we in 2015?

Complex CAD (5) PVD-P Valv. CM. Sub-Clinical Arterial (2) DBD/Frailty (2) Health Political (1) Personal (3)

Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease

Left Main Intervention: Will it become standard of care?

FFR and ifr: Similarities, Differences, and Clinical Implication

Introducing. Integrated FFR Platform

ORIGINAL ARTICLE. Abstract. Introduction

Controversies in Cardiac Surgery

Left Main PCI. Integrated Use of IVUS and FFR. Seung-Jung Park, MD, PhD

The fluid, dynamic interaction of multiple sequential

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Upgrade of Recommendation

Blinded Physiological Assessment of Residual Ischemia after Successful Angiographic PCI Allen Jeremias, MD, MSc

PCI for Stable Ischemic Heart Disease: What Happened in the Last Week?

Relations of Interest

FRACTIONAL FLOW RESERVE: CONCEPT, EXPERIMENTAL BASIS, CUT-OFF VALUES

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

The Latest on CT Fractional Flow Reserve. Dimitris Mitsouras, Ph.D.

Fractional Flow Reserve: Clinical Trials Update

Approach to Multi Vessel disease with STEMI

CARDIOLOGY GRAND ROUNDS

Clinical case in perspective. Cases from Poland

A Novel Simple Technique Using Hyperemia to Enhance Pressure Gradient Measurement of the Lower Extremity During Peripheral Intervention

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

Novel insights into the complexity of ischaemic heart disease derived from combined coronary pressure and flow velocity measurements van de Hoef, T.P.

The SYNTAX-LE MANS Study

Percutaneous Coronary Intervention: Update

Stable Angina: Indication for revascularization and best medical therapy

Transcription:

FRACTIONAL FLOW RESERVE USE IN THE CATH LAB BECAUSE ANGIOGRAPHY ALONE IS NOT ENOUGH!!!!!!!! Juan Antonio Pastor-Cervantes,M.D FSCAI, FACC Cardiovascular Institute Memorial Regional Hospital Hollywood Florida

Implementing FFR Interventional cardiologist s job is to diagnose and treat ischemic stenoses in major epicardial vessels It is often difficult to tell the physiologic severity of a stenosis on an angiogram We should be treating only the significant stenoses with PCI Stenting a stenosis that is non-ischemic does not help a patient We do not cure CAD, but we hope that we alter the slope of our patients decline in a positive way.

Why learn to measure FFR? Stress test in the Cath Lab that tells you the physiologic significance of a coronary stenosis quickly and accurately Significant % of stenoses of intermediate severity. You can diagnose significant lesions that don t look severe angiographically. You can avoid getting yourself into PCIs you wish you hadn t started. You can evaluate your result after stenting. Pre and Post FFR can be measured with the wire used to deliver the stent.

Three subsets of patients where having FFR capability changes things Borderline/moderate stenoses, especially in the proximal LAD Diffusely diseased arteries Multi-vessel disease It s difficult to do these kinds of cases confidently without FFR

#1 Fundamental Interventional Truth That Drives the Concept of FFR Lesions causing ischaemia are prognostically important... There is no benefit to treating lesions without ischaemia

In patients with a similar degree of anatomic disease the most important predictor of outcome is the presence and extent of inducible ischaemia The risk for death or MI in the next 5 years is thus 20 times higher for an ischaemic lesion compared to a non-ischaemic one 12000 patients with similar coronary stenosis severity at angio 24-Sep-11

Fundamental Truth #2: If ischaemia, rather than anatomy, is what you are interested in then: Current Non Invasive Tests Have Disadvantages

So.. We need a test that will direct us to what needs revasc and what doesn t We need a definitive test for ischaemia at the time of angiography to make a diagnosis We need a test that will tell us when we have succeeded

Incorporating Physiology

What is Maximal Hyperemia? Maximal Hyperemia Means Maximal Vasodilation or Maximal Possible Blood-Flow to the Myocardium

Flow-Pressure Relationship 100% FFR=1.0 We are measuring coronary pressure to measure coronary flow Flow Pa/Pd (Pressure) It is at the point of maximal hyperemia that FFR is proportional to blood flow At this point further blood flow is impossible, thus 100% flow = FFR 1.0

Flow-Pressure Relationship Significant Coronary Stenosis Normal maximum flow maximum hyperemia = true FFR 70% Flow FFR=0.7 Pa/Pd (Pressure) With a stenosis, maximal blood flow is lower despite maximal stimulation of the microvasculature - in this case only reaching 70% compared to normal The corresponding Pd/Pa pressure will therefore be proportional to the flow at this new point 70% blood flow is proportional to FFR=0.70

Pharmacologic Hyperemic Stimuli Intravenous Adenosine Infusion Current gold standard for FFR measurement Hyperemia mediated via A2 receptor on cell membrane on resistance vessels Exogenously administered adenosine causes profound microvascular dilation Hyperemia is independent of metabolic demand Produces steady-state hyperemia

Intravenous Adenosine Dose: 140 mcg/kg/min Effects Peak Effect Duration of Effect Side Effects AV Block Do NOT use in pts. with Asthma/COPD <2 min Within 2 min after D/C rare Bronchospasm BP and HR Usually 10-20% Burning sensation in chest Harmless, not ischemia, resolves within few min.

Advantages Intravenous Adenosine Give IC NTG prior to Measurement Steady State Hyperemia Measurement of CFR possible Limitations Infusion in Femoral Vein High-Volume Infusion Pump Required Setup cumbersome and time consuming Pullback curve Assessment of Microvascular Disease Large cubital vein alternative Inadequate infusion leads to suboptimal hyperemia Routine Use Improves Efficiency

Effects Peak Effect Intracoronary Adenosine Dose: 40-60 mcg in LCA; 20-40 mcg in RCA Duration of Effect Side Effects/Precautions AV Block 10 sec 20 sec Common; Transient Do NOT use Guide with SH Inadequate Drug Delivery Do NOT use Guide when Pressure Damped Interruption of Pa as short as possible Pa underestimated, FFR If too long, peak hyperemia may be missed

Intracoronary Adenosine Give IC NTG prior to Measurement Advantages Easy Administration Rapid Testing Limitations Pull-Back Curve not Possible Measurement of CFR not Possible Dose Escalation Frequently Necessary No IV Setup Required No Central Vein Access No Wait for Max. Hyperemia Hyperemia too Transient Hyperemia too Transient Sub-Maximal Hyperemia at Lower Doses

FFR-Guided PCI performed on indicated lesions only if FFR <0.80 Flow Chart Lesions warranting PCI identified Randomized Primary Endpoint Composite of death, MI and repeat revasc. (MACE) at 1 year Key Secondary Endpoints Individual rates of death, MI, and repeat revasc., MACE, and functional status at 2 years Angio-Guided PCI performed on indicated lesions

2 Year Survival Free of Death/MI FFR-Guided Angio-Guided 730 days 4.3% P-value 0.03* Data presented at TCT Late Breaking Trial Session September 23, 2009 * By chi-square testing

FFR-guidance in multivessel disease PCI Some criticism. I do not stent lesions unless they are at least 70%, what about that? Or Do we really have to measure FFR in all these lesions?

Flow Chart FFR-Guided PCI performed on indicated lesions only if FFR <0.80 Lesions warranting PCI identified Randomized Angio-Guided PCI performed on indicated lesions Before randomization the operator indicated all stenoses 50% requiring stenting and classified them into: 50-70%, 71-90% and 91-99% In the FFR-group all indicated lesions were measured by FFR (N=1329)

FFR versus angiography Submitted data

routine stenting of stenoses of 50-70%, based on the angiogram, means unnecessary stenting in 65% of such stenoses 65 % Submitted data

not stenting 50-70% lesions routinely, leaves 35% of ischemic stenoses untreated 65 % 35 % Submitted data

In stenoses between 71 and 90% narrowed, the percentage of unnecessary stent placement, is 20% 65 % 20 % 35 % Submitted data

Almost all stenoses >90% narrowed are significant by FFR 65 % 20 % 4% 20 % 35 % Submitted data

Angiography versus FFR In patients with multivessel CAD, whether or not taking into account clinical data one cannot rely on the angiogram to identify ischemia-producing lesions when assessing stenoses between 50 and 90% In this setting, routine stenting without FFR guidance is justified only for stenoses >90%, because almost all of these lesions are functionally significant

Anatomic vs. Functional CAD 0VD (9%) 3VD (14%) Angiographic 3 Vessel 1VD (34%) 2VD (43%) Disease Tonino et al., JACC 2010 (submitted)

Let s go to a case example, a FAME-like patient A rather common patient in our cath lab today. male born 1952 Smoker Admitted with USA Referred for Cath

70% stenosis prox LAD 70% stenosis ostium OMCX Clinical dilemma: what should we do? MVS vs. CABG

50-70% stenosis PLRCA 80% + 2x 50% stenosis in RPDA

Pressure wire in LAD

hyperemia resting FFR LAD (i.v. adenosine)

Pressure wire in OMCX

rest adenosine pull-back FFR meaasurement in OMCX

Pressure wire in PL-RCA

resting hyperemia FFR measurement in PL-RCA

Pressure wire in RPDA

resting hyperemia FFR measurement in RPDA

FFR in PCI: deferring therapy JACC 2007;49:2105-2111

Potential Pitfalls Wiring the Lesion Consider disconnecting the wire from the interface connector Distal end of wire Can use exchange catheter to more safely position pressure wire Interface connector

Potential Pitfalls Recognizing Drift True Gradient Drift Adapted from Pijls et al. Cathet Cardiovasc Intervent 2000;49:1-16

Potential Pitfalls Inadequate hyperemia Intravenous adenosine Should be administered via central vein May require higher doses (>140 ug/kg/min) if given peripherally If the patient doesn t develop symptoms and/or hemodynamic changes, the patient is likely not receiving IV adenosine

Catheter Issues FFR of the LAD Is this correct?

Impact of Catheter Size on Hyperemic Flow De Bruyne et al. Cathet Cardiovasc Diagn 1994;33:145-152.

Catheter Issues Unseating of Guide Catheter Reveals True FFR

Conclusion The Clinical Value of the Concept FFR measurement has expanded our ability to deliver ischaemia-driven therapy FFR allows us to tell which lesions are significant & just as importantly which aren t!! FFR allows us to check that we have stented successfully What effect would a routine pressure wire-directed approach pre- and post-stenting have had on the outcome of: ARTS? SYNTAX? COURAGE??

THANK YOU 9/24/2011

Toyohashi Heart Center